Allergic-Specific Immunotherapy Using Injectable In Situ Crosslinked Hyaluronic Acid Hydrogels Ameliorates Allergic Response in Murine Allergic Rhinitis Model

被引:0
|
作者
Lee, Hyun Jong [1 ]
Kim, Ji An [2 ]
Lee, Yerin [1 ]
Lim, Saebin [1 ]
Chun, Yoon Hong [2 ]
机构
[1] Gachon Univ, Sch Chem Biol & Battery Engn, Seongnam, South Korea
[2] Catholic Univ Korea, Dept Pediat, Incheon St Marys Hosp, Coll Med, 56 Dongsu Ro, Incheon 21431, South Korea
基金
新加坡国家研究基金会;
关键词
Allergen immunotherapy; allergic rhinitis; house dust mites; hyaluronic acid; hydrogels; RHINOCONJUNCTIVITIS;
D O I
10.4168/aair.2025.17.1.60
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose: We present a convenient and safe allergen-specific immunotherapy using injectable hyaluronic acid (HA) hydrogel containing house dust mite (HDM) crosslinked via visible- light-induced thiol-ene reaction. Methods: We developed 2 types of HDM-containing HA hydrogels, namely thiolated HA (SH-HA) + methacrylated HA (MA-HA) (Gel-1) and 4-arm poly (ethylene glycol) (PEG)-SH + MA-HA (Gel-2). The immunotherapeutic effect of the hydrogels was tested using a murine model of allergic rhinitis. Sensitized mice received 3 subcutaneous injections of the HDM extract (subcutaneous immunotherapy [SCIT] group) or phosphate buffer saline (negative and positive control) at 2-day intervals. Mice in the HA hydrogel immunotherapy groups received one subcutaneous injection of each HA hydrogel precursor solution that formed hydrogel by transmitting blue light through the skin. All except the negative control received HDM extract intranasally for 5 days. Nasal symptoms, ear swelling, eosinophil count, antibody levels, and histopathology of the nasal mucosa were analyzed. Results: All HDM-containing immunotherapy groups exhibited reduced nasal symptoms, ear swelling, and eosinophil count in nasopharyngeal lavage compared to the positive control group. Eosinophils, mast cells, and goblet cells in the nasal mucosa decreased in all treatment groups compared to the positive control group. The serum levels of HDM-specific immunoglobulin G (IgG)1 increased in all treatment groups; however, IgG2a levels increased only in the SCIT and Gel-2 groups. Interleukin (IL)-4, 13, and 17 decreased in all treatment groups compared to those in the positive control group, whereas IL-10level increased only in the SCIT and Gel-2 groups. SCIT and Gel-2 treatment showed similar capability to induce regulatory T cells. Conclusions: Injectable HA hydrogel containing HDM reduced allergic symptoms and induced tolerance in a murine model of allergic rhinitis.
引用
收藏
页码:60 / 76
页数:17
相关论文
共 50 条
  • [1] Allergic-specific immunotherapy using injectable in situ crosslinked hyaluronic acid hydrogels
    Chun, Yoonhong
    Kim, Ji An
    Lee, Yerin
    Lim, Saebin
    Lee, Hyun Jong
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB149 - AB149
  • [2] IL-37 ameliorates allergic inflammation in a house dust mite allergic rhinitis murine model
    Kim, D. H.
    Kim, S. W.
    ALLERGY, 2016, 71 : 24 - 24
  • [3] Allergen-specific sublingual immunotherapy is dose and duration dependent in a murine allergic rhinitis model
    Tofukuji, Soichi
    Katayama, Kazufumi
    Nakano, Yoshiyuki
    Ishida, Satoru
    Tsuchida, Junji
    Tajiri, Minako
    Shimo, Yusuke
    Tanaka, Hidekazu
    Shichijo, Michitaka
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (06) : 1977 - +
  • [4] Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model
    Isik, Sakine
    Karaman, Meral
    Adan, Aysun
    Kiray, Muge
    Bagriyanik, Husnu Alper
    Sozmen, Sule Caglayan
    Kozanoglu, Ilknur
    Karaman, Ozkan
    Baran, Yusuf
    Uzuner, Nevin
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2017, 274 (01) : 197 - 207
  • [5] Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model
    Sakine Işık
    Meral Karaman
    Aysun Adan
    Müge Kıray
    Hüsnü Alper Bağrıyanık
    Şule Çağlayan Sözmen
    İlknur Kozanoğlu
    Özkan Karaman
    Yusuf Baran
    Nevin Uzuner
    European Archives of Oto-Rhino-Laryngology, 2017, 274 : 197 - 207
  • [6] Experimental sublingual allergen immunotherapy with monomeric allergoid in a murine model of allergic rhinitis
    Laskin, A. A.
    Babakhin, A. A.
    Kamishnikov, O. Y.
    Chuvirov, D. G.
    Andreev, S. M.
    Khaitov, M. R.
    ALLERGY, 2015, 70 : 230 - 231
  • [7] Effect of intralymphatic allergen-specific immunotherapy on house dust mite in a murine model of allergic rhinitis
    Jung, Joo Hyun
    Kim, Kyeong Ah
    Choi, Yun Sook
    Kim, Seon Tae
    ACTA OTO-LARYNGOLOGICA, 2023, 143 (10) : 867 - 875
  • [8] Inhibition of Allergic Response by Intranasal Selective NF-κB Decoy Oligodeoxynucleotides in a Murine Model of Allergic Rhinitis
    Wee, Jee Hye
    Zhang, Yu-Lan
    Rhee, Chae-Seo
    Kim, Dong-Young
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2017, 9 (01) : 61 - 69
  • [9] MicroRNA-133b Ameliorates Allergic Inflammation and Symptom in Murine Model of Allergic Rhinitis by Targeting Nlrp3
    Xiao, Lifeng
    Jiang, Li
    Hu, Qi
    Li, Yuru
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (03) : 901 - 912
  • [10] Mouse model for house dust mite (HDM)-specific immunotherapy in allergic rhinitis
    Oh, J.
    Ko, Y. K.
    Yang, S. K.
    Kim, D. Y.
    Rhee, C. S.
    Han, D. H.
    ALLERGY, 2023, 78